Biovica's IPO

Biovica raised a round of funding on March 29, 2017. Investors include Public.

Biovica (NASDAQ Stockholm: BIOVIC B) is a biotech company developing blood-based biomarker assays that improve the monitoring of modern cancer therapies and better predict patient outcome. The company…

Articles about Biovica's IPO: